Conflict of interest statement: Competing Interests: The authors have declaredthat no competing interest exists.14. J Cancer. 2018 Apr 6;9(8):1430-1436. doi: 10.7150/jca.21281. eCollection 2018.Survivorship and Advocacy in Inflammatory Breast Cancer.Alexander A(1)(2), Arnold TL(3), Bishnoi S(4)(5), Ballinger C(6), ShaitelmanSF(7), Schaverien MV(8), Cohen L(9), Dev M(1), Ueno NT(1)(2).Author information: (1)Department of Breast Medical Oncology, The University of Texas MD AndersonCancer Center, Houston TX.(2)Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, TheUniversity of Texas MD Anderson Cancer Center, Houston TX.(3)The IBC Network Foundation.(4)Rice 360 Program, Rice University, Houston TX.(5)Metastatic Breast Cancer Network.(6)The IBC Network UK.(7)Department of Radiation Oncology, The University of Texas MD Anderson CancerCenter, Houston TX.(8)Department of Plastic Surgery, The University of Texas MD Anderson CancerCenter, Houston TX.(9)Integrative Medicine Program, The University of Texas MD Anderson CancerCenter, Houston TX.In February 2017, the Morgan Welch Inflammatory Breast Cancer (IBC) ResearchProgram and Clinic hosted a scientific conference in Houston to commemorate thetenth anniversary of the opening of the first IBC-dedicated clinic in the world. Attendees included basic science researchers, clinicians who treat IBC, as wellas patients and their caregivers. Several US-based and international IBC-focused nonprofit organizations were also represented. In this third paper from theconference, we report on the breakout session regarding survivorship and advocacyissues related to IBC, sharing an overview of the educational content presentedand discussions regarding the future of IBC advocacy. Panelists focused onlymphedema research and clinical solutions, integrative medicine, and socialwork, with time provided for questions in small groups. IBC nonprofits that areleading advocacy efforts were introduced, and ways to become involved in theseinitiatives were discussed. Priorities for future advocacy and clinical careneeds were also highlighted. In addition to summarizing these topics, we provide a suggested integrated IBC-specific plan of care that could be provided to thepatient at the beginning of care and referred to throughout treatment andfollow-up.DOI: 10.7150/jca.21281 PMCID: PMC5929088PMID: 29721053 